GTC Biotherapeutics (fka GTCB)

[keitern]

Jesse, I think the other side of it is the R&D and engineering. It is impossible for me to quantify, but I have sensed that GTCB engineers have a greater control over the process. Given an objective within the scope of the platform, they seem to have a high degree of confidence that they can produce the required drug per specifications. Perhaps this is not that unique. Maybe the state of genetically engineered drugs is such that all or most of the producers have a high degree of confidence that they can produce what is required.

At any rate, I am interested in trying to get a handle on the risks associated with this company vis. other bio techs.